跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXMEDETOMIDINE MEDICIANZ dexmedetomidine (as hydrochloride) 400 microgram/4 mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DEXMEDETOMIDINE MEDICIANZ dexmedetomidine (as hydrochloride) 400 microgram/4 mL concentrated injection vial
Approved
STANDARD
DEXMEDETOMIDINE MEDICIANZ dexmedetomidine (as hydrochloride) 400 microgram/4 mL concentrated injection vial
Medsurge Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
3a99cbe4dc652783
Company
Medsurge Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
3a99cbe4dc652783
Product Name
DEXMEDETOMIDINE MEDICIANZ dexmedetomidine (as hydrochloride) 400 microgram/4 mL concentrated injection vial
Artg Id
352315
Artg Name
DEXMEDETOMIDINE MEDICIANZ dexmedetomidine (as hydrochloride) 400 microgram/4 mL concentrated injection vial
Sponsor
Medsurge Pharma Pty Ltd
Company Detail Path
/organization/medsurge-pharma-pty-ltd
Artg Date
2021-11-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
3a99cbe4dc652783
Type
Standard
Back to TGA Approvals
